Corporate & Securities Law Community | LexisNexis
Featured Content

Tom Moylan

LexisNexis Torts Law Center Staff

Tom Moylan is a legal journalist who has covered product liability litigation and mass torts for the past 15 years.  He currently edits Mealey’s Emerging Drugs & Devices Report, a twice-monthly litigation newsletter for plaintiff and defense attorneys.  He is a contributor to LexisNexis Legal News podcasts.  He also oversees Mealey’s separate litigation reports on diet drugs (fen-phen), vaccines, arthritis drugs (Vioxx), hormone therapy drugs (Prempro), Yaz/Yasmin contraceptives, and heart drugs and medical devices.  He holds a master’s degree in journalism from The Ohio State University and has 18 years of experience working as a reporter and editor for two newspapers.  His reporting has earned him awards from the American Bar Association, the Pennsylvania Bar Association, the Pennsylvania Newspaper Association and the Society of Professional Journalists.


My Comments

No one has commented on Tom Moylan.